Pavon Narciso, Sun Yubing, Pak ChangHui
Department of Biochemistry and Molecular Biology, University of Massachusetts Amherst, Amherst, MA, United States.
Graduate Program in Neuroscience and Behavior, University of Massachusetts Amherst, Amherst, MA, United States.
Front Genet. 2024 Sep 26;15:1440583. doi: 10.3389/fgene.2024.1440583. eCollection 2024.
Neural organoids have emerged as valuable tools for studying the developing brain, sparking enthusiasm and driving their adoption in disease modeling, drug screening, and investigating fetal neural development. The increasing popularity of neural organoids as models has led to a wide range of methodologies aimed at continuous improvement and refinement. Consequently, research groups often improve and reconfigure protocols to create region-specific organoids, resulting in diverse phenotypes, including variations in morphology, gene expression, and cell populations. While these improvements are exciting, routine adoptions of such modifications and protocols in the research laboratories are often challenging due to the reiterative empirical testing necessary to validate the cell types generated. To address this challenge, we systematically compare the similarities and differences that exist across published protocols that generates subpallial-specific organoids to date. In this review, we focus specifically on exploring the production of major GABAergic neuronal subtypes, especially Medium Spiny Neurons (MSNs) and Interneurons (INs), from multiple subpallial organoid protocols. Importantly, we look to evaluate the cell type diversity and the molecular pathways manipulated to generate them, thus broadening our understanding of the existing subpallial organoids as well as assessing the applicability of specific patterning factors. Lastly, we discuss the current challenges and outlook on the improved patterning of region-specific neural organoids. Given the critical roles MSN and IN dysfunction play in neurological disorders, comprehending the GABAergic neurons generated by neural organoids will undoubtedly facilitate clinical translation.
神经类器官已成为研究发育中大脑的宝贵工具,激发了人们的热情,并推动其在疾病建模、药物筛选和胎儿神经发育研究中的应用。神经类器官作为模型越来越受欢迎,这导致了旨在持续改进和完善的广泛方法。因此,研究小组经常改进和重新配置方案以创建区域特异性类器官,从而产生多种表型,包括形态、基因表达和细胞群体的变化。虽然这些改进令人兴奋,但由于验证所生成细胞类型所需的反复实证测试,研究实验室中常规采用此类修改和方案往往具有挑战性。为应对这一挑战,我们系统地比较了迄今为止已发表的生成皮质下特异性类器官的方案之间存在的异同。在这篇综述中,我们特别关注从多种皮质下类器官方案中探索主要GABA能神经元亚型的产生,尤其是中型多棘神经元(MSN)和中间神经元(IN)。重要的是,我们希望评估细胞类型多样性以及为生成它们而操纵的分子途径,从而拓宽我们对现有皮质下类器官的理解,并评估特定模式因子的适用性。最后,我们讨论了当前区域特异性神经类器官改进模式面临的挑战和前景。鉴于MSN和IN功能障碍在神经系统疾病中所起的关键作用,了解神经类器官产生的GABA能神经元无疑将促进临床转化。